Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Masching, Alexandra [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2047
引用
收藏
页码：S1168 / S1168
页数：1
相关论文
共 50 条
  • [41] EFFICACY OF USTEKINUMAB FOR INDUCTION AND MAINTENANCE OF HISTOLOGICAL HEALING IN PATIENT'S WITH CROHN'S DISEASE
    Li, K.
    Chan, D.
    Pollack, P.
    Jacobstein, D.
    Brodmerkel, C.
    Gasink, C.
    Feagan, B.
    Sandborn, W.
    Rutgeerts, P.
    De Hertogh, G.
    GUT, 2017, 66 : A123 - A123
  • [42] Use of Ustekinumab in a Patient With Penetrating Crohn's Disease Complicated With Sacral Osteomyelitis
    Boarini, Lucas R.
    Garcia, Jessica B.
    Boarini, Marcelo R.
    Altikes, Renato G.
    Pileggi, Gustavo M.
    Boarini, Paulo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S40 - S40
  • [43] EFFICACY OF USTEKINUMAB FOR INDUCTION AND MAINTENANCE OF HISTOLOGICAL HEALING IN PATIENT'S WITH CROHN'S DISEASE
    Li, Katherine
    Chan, Daphne
    Pollack, Paul
    Jacobstein, Douglas
    Brodmerkel, Carrie
    Gasink, Christopher
    Feagan, Brian G.
    Sandborn, William J.
    Rutgeerts, Paul
    De Hertogh, Gert
    GASTROENTEROLOGY, 2017, 152 (05) : S595 - S595
  • [44] Ustekinumab: A Review in Moderate to Severe Crohn’s Disease
    Yvette N. Lamb
    Sean T. Duggan
    Drugs, 2017, 77 : 1105 - 1114
  • [45] Ustekinumab effectiveness in Crohn's disease with lesions in the intestines
    Tamura, Satoshi
    Asai, Yusuke
    Ishida, Natsuki
    Miyazu, Takahiro
    Tani, Shinya
    Yamade, Mihoko
    Hamaya, Yasushi
    Iwaizumi, Moriya
    Osawa, Satoshi
    Furuta, Takahisa
    Sugimoto, Ken
    MEDICINE, 2024, 103 (15) : E35647
  • [46] Ustekinumab in Crohn's disease: experience in a regional hospital
    Trujillano, A.
    Maestre, M. A.
    Galan, N.
    Cano, V.
    Morego, A.
    Bello, M.
    Llodra, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 815 - 815
  • [47] Rapid Resolution of Vulvar Crohn's Disease With Ustekinumab
    Stoleru, Gianna
    Robbins, Gordon
    Papadimitriou, John C.
    Wong, Uni
    ACG CASE REPORTS JOURNAL, 2020, 7 (08)
  • [48] Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
    Feagan, B. G.
    Sandborn, W. J.
    Gasink, C.
    Jacobstein, D.
    Lang, Y.
    Friedman, J. R.
    Blank, M. A.
    Johanns, J.
    Gao, L. -L.
    Miao, Y.
    Adedokun, O. J.
    Sands, B. E.
    Hanauer, S. B.
    Vermeire, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J.
    Colombel, J. -F.
    Tulassay, Z.
    Seidler, U.
    Salzberg, B. A.
    Desreumaux, P.
    Lee, S. D.
    Loftus, E. V., Jr.
    Dieleman, L. A.
    Katz, S.
    Rutgeerts, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20): : 1946 - 1960
  • [49] Trough levels and antibodies to ustekinumab are not correlated to response to ustekinumab treatment in Crohn's disease patients
    Claire, P.
    Severine, B.
    Nicolas, D.
    Maria, N.
    Pierre, D.
    Julien, B.
    Romain, G.
    Medina, B.
    Myriam, L.
    Benjamin, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S260 - S261
  • [50] Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease
    Painchart, Claire
    Brabant, Severine
    Duveau, Nicolas
    Nachury, Maria
    Desreumaux, Pierre
    Branche, Julien
    Gerard, Romain
    Prevost, Clementine Lauriot Dit
    Wils, Pauline
    Lambin, Thomas
    Boualit, Medina
    Labalette, Myriam
    Pariente, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (05) : 1445 - 1452
12345